SMTL ID : 8arj.1

Anaplastic Lymphoma Kinase with a novel carboline inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.64 Å

Oligo State

monomer

Ligands

1 x NRR: 3-(dimethylamino)-1-[3-[4-(4-methylpiperazin-1-yl)phenyl]-9~{H}-pyrido[2,3-b]indol-6-yl]prop-2-en-1-one(Non-covalent)

NRR.1: 20 residues within 4Å: Chain A: L.32, V.40, A.58, K.60, V.90, L.106, E.107, L.108, M.109, A.110, G.112, D.113, S.116, E.120, R.163, N.164, L.166, G.179, D.180, F.181 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.32, A:L.106, A:L.166, A:L.166 Hydrogen bonds: A:K.60, A:E.107, A:M.109 Water bridges: A:E.77 Salt bridges: A:E.120

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mologni, L. et al., Discovery of Novel alpha-Carboline Inhibitors of the Anaplastic Lymphoma Kinase. Acs Omega (2022)

Release Date

2022-09-14

Peptides

ALK tyrosine kinase receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK tyrosine kinase receptor